Researchers are using artificial intelligence to personalize cancer treatments, with recent positive developments in a Phase 3 melanoma trial by Moderna and Merck. The study involved 1,137 participants and tested intismeran autogene (V940) alongside Keytruda, showing significant results for recurrence-free survival and distant metastasis-free survival. However, the article emphasizes that while these findings are promising, detailed data from the trial has not yet been released, so the full impact of this AI-driven therapy remains to be seen.
Written by the local model on 2026-09-14,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Researchers are now using artificial intelligence to help tailor cancer treatments and uncover overlooked uses for existing medicines.
asserted
Researchers → use → medicines
Other systems can search microscopic images or identify subtle biological signals that people could easily miss.
uncertain
people → search → that
Some of these technologies have already helped patients.
asserted
Some → help → patients
Others remain in clinical trials or research labs, so we need to be careful about separating promising science from treatments you can actually receive today.
asserted
you → remain → treatments
Still, what researchers are accomplishing would have been difficult to imagine a few years ago.
asserted
accomplishing → accomplish → what
Here's where AI is already changing medicine and what you should know before trusting it with your health.
asserted
you → change → health
Join our upcoming CyberGuy LIVE class: Get Better Healthcare With AI
In this free live online class, Kurt "CyberGuy" Knutsson will show you five practical ways AI can help you take a more active role in your healthcare.
asserted
you → join → healthcare
You’ll learn how to organize your health history, remember important appointment details, understand complicated medical information, research prescriptions and prepare questions for your next doctor’s visit.
asserted
You → learn → visit
No technical experience is needed.
asserted
experience → need → ?
Register for free now at CyberGuyLive.com
AI helps personalize an experimental melanoma treatment
One of the biggest recent developments comes from Moderna and Merck.
asserted
One → register → Moderna
On Aug. 19, the companies announced positive topline results from a Phase 3 melanoma trial.
asserted
companies → announce → trial
The study tested intismeran autogene, also known as V940 or mRNA-4157, alongside Keytruda.
asserted
study → test → Keytruda
The trial enrolled 1,137 people with high-risk melanoma that surgeons had completely removed.
asserted
surgeons → enrol → that
The combination met its primary endpoint for recurrence-free survival.
asserted
combination → meet → survival
It also met a key secondary endpoint measuring distant metastasis-free survival.
asserted
It → meet → survival
Merck and Moderna said this was the first positive Phase 3 readout for an individualized neoantigen therapy.
asserted
this → say → therapy
It was also the first positive Phase 3 result for an mRNA-based cancer therapy.
asserted
It → base → therapy
That sounds complicated, but the basic idea is fascinating.
asserted
idea → sound → ?
Researchers start with a sample of a patient's tumor.
asserted
Researchers → start → tumor
They analyze its unique mutations and use an algorithm to select targets that may help the immune system recognize the cancer.
uncertain
system → analyze → cancer
The resulting individualized therapy can encode up to 34 neoantigens.
asserted
therapy → result → neoantigens
Moderna has also said the V940 program uses integrated AI algorithms during the development process.
asserted
program → say → process
The company then creates an mRNA treatment based on the selected targets.
asserted
company → create → targets
You may have seen this approach called a personalized cancer vaccine.
uncertain
You → see → approach
Moderna and Merck currently describe intismeran as an individualized neoantigen therapy.
asserted
Moderna → describe → therapy
The goal is to train the immune system to recognize characteristics unique to that patient's cancer.
asserted
system → train → cancer
What the melanoma results actually tell us
asserted
tell → tell → us
Merck and Moderna have announced only topline results from the Phase 3 trial so far.
asserted
Merck → announce → trial
The companies plan to present the full findings at an international medical meeting and share them with regulators.
asserted
companies → plan → regulators
The study also continues to track overall survival.
asserted
study → continue → survival
Earlier results offer additional context.
asserted
results → offer → context
In a smaller Phase 2b study with longer follow-up, intismeran plus Keytruda reduced the risk of recurrence or death by 49% compared with Keytruda alone.
asserted
intismeran → reduce → Keytruda
It also reduced the risk of distant metastasis or death by 59%.
asserted
It → reduce → %
Those earlier results came from a much smaller patient group.
asserted
results → come → group
That makes the larger Phase 3 trial an important step forward.
asserted
trial → make → ?
Still, intismeran remains investigational.
asserted
intismeran → remain → ?
The FDA has not approved intismeran as a melanoma treatment.
asserted
FDA → approve → treatment
AI can search existing drugs for completely new uses
Developing a new medicine can take years.
asserted
Developing → search → years
Another group of researchers is asking a different question: What if a useful treatment already exists?
asserted
treatment → ask → question
Dr. David Fajgenbaum co-
asserted
Fajgenbaum → co → ?
…and 122 more, not listed.
